CEO: Douglas S. Ingram

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.


Key numbers

Market Capitalization:7264960780
Shares Outstanding: 74543000
Float: 70530052.138
Next Earning Date:2020-02-25
TTm EPS: -8.5611
TTm Dividend Rate:
200 days moving average:117.03
50 days moving average: 86
One day percent Change: 4.97



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,